Optimizing and Validating Analytical Pharmaceutical Methods

DSI can supervise the development of analytical methodologies for use in the control of starting materials, drug substances, and drug products.

Image Credit: DS InPharmatics

This covers the complete lifecycle of methodology involving creation, optimization, transfer, and validation. DSI has an analytical development team with experience in comprehensive methods development and validation.

Services

  • Development of analytical strategy
  • Analytical testing/Validation strategy
  • Development of IPC & PAT method
  • Development support for drug substance and drug product analytical methods
  • Report documentation

Advantages

  • Ability to stage suitable analytical strategies
  • Gain access to a significantly experienced industry team

About DS InPharmatics 

DS InPharmatics (DSI) provides regulatory, technical, and project management consulting services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products.

Since 2007 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence. Whether advocating CMC strategy, directing CMC operations or developing CMC submission content that represent the best interests of emerging biotech, we focus on the critical CMC issues and build programs that enhance development.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Mar 14, 2024 at 10:21 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    DSI, a PLG Company. (2024, March 14). Optimizing and Validating Analytical Pharmaceutical Methods. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/whitepaper/20200508/Optimizing-and-Validating-Analytical-Pharmaceutical-Methods.aspx.

  • MLA

    DSI, a PLG Company. "Optimizing and Validating Analytical Pharmaceutical Methods". News-Medical. 25 April 2024. <https://www.news-medical.net/whitepaper/20200508/Optimizing-and-Validating-Analytical-Pharmaceutical-Methods.aspx>.

  • Chicago

    DSI, a PLG Company. "Optimizing and Validating Analytical Pharmaceutical Methods". News-Medical. https://www.news-medical.net/whitepaper/20200508/Optimizing-and-Validating-Analytical-Pharmaceutical-Methods.aspx. (accessed April 25, 2024).

  • Harvard

    DSI, a PLG Company. 2024. Optimizing and Validating Analytical Pharmaceutical Methods. News-Medical, viewed 25 April 2024, https://www.news-medical.net/whitepaper/20200508/Optimizing-and-Validating-Analytical-Pharmaceutical-Methods.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.